http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9702170-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 1995-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eac127695d70657c758741552aa0826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95227de1bd7603338f6d907de7345c90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e42ce096d45b18c53925733a2fd12d6
publicationDate 1998-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9702170-A
titleOfInvention USE OF AROMATASE INHIBITORS FOR THE PRODUCTION OF A PHARMACEUTICAL AGENT FOR THE TREATMENT OF A RELATIVE ANDROGEN DEFICIENCY IN MEN.
abstract The present invention relates to the use of aromatase inhibitors in the preparation of a drug to treat a relative androgen deficiency in men. Selective aromatase inhibitors, such as, for example, atamestane. Formestane, Pentrozole, Arimidex, Fadrozole, CGS 20267 and / or Vorozole are preferably used to prepare the drug according to the invention.
priorityDate 1994-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408128213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501829

Total number of triples: 45.